Company Filing History:
1 out of 5,076 
1 out of 1,743 
Years Active: 2024
Title: Giorgia Maria Laura Urbinati: Innovator in Antisense RNA Technology
Introduction
Giorgia Maria Laura Urbinati is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of antisense RNA therapies. Her innovative work focuses on addressing genetic disorders, showcasing her commitment to advancing medical science.
Latest Patents
Giorgia holds a patent for "Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease." This invention relates to antisense RNAs that target PMP22 and can inhibit the expression of this gene by 40% to 60% in cells. The patent emphasizes the use of siRNA, preferably delivered in the form of nanoparticles, for therapeutic applications. This groundbreaking work aims to provide new treatment options for individuals affected by Charcot-Marie-Tooth 1A disease.
Career Highlights
Throughout her career, Giorgia has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant research initiatives.
Collaborations
Giorgia has collaborated with notable colleagues, including Liliane Massade and Charbel Massaad. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Giorgia Maria Laura Urbinati is a trailblazer in the field of antisense RNA technology, with a focus on treating genetic disorders. Her patent and collaborations reflect her dedication to improving healthcare through innovative solutions. Her work continues to inspire future advancements in biotechnology.